Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults
Clinical trial NCT01369862 · COMPLETED
Trial details
- NCT number
- NCT01369862
- Sponsor
- AVIR Green Hills Biotechnology AG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-08-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.